BioCorRx (BICX) Financial Statements

5 Followers

BioCorRx Financial Overview

BioCorRx's market cap is currently $10.56M. The company's EPS TTM is $-0.07; its P/E ratio is -1.56; BioCorRx is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	$ 797.24K	$ 7.67K	$ 89.16K	$ 213.84K	$ 48.27K
Gross Profit	$ 691.38K	$ 6.00K	$ 53.17K	$ 198.56K	$ 42.39K
Operating Income	$ -4.83M	$ -5.12M	$ -3.79M	$ -2.91M	$ -4.53M
EBITDA	$ -2.56M	$ -3.59M	$ -2.68M	$ -3.15M	$ -4.48M
Net Income	$ -3.44M	$ -5.11M	$ -3.77M	$ -4.37M	$ -5.80M
Balance Sheet
Cash & Short-Term Investments	$ 139.36K	$ 88.03K	$ 65.22K	$ 68.61K	$ 85.84K
Total Assets	$ 2.15M	$ 385.94K	$ 388.89K	$ 766.59K	$ 819.98K
Total Debt	$ 2.13M	$ 2.81M	$ 1.81M	$ 1.68M	$ 1.77M
Net Debt	$ 1.99M	$ 2.72M	$ 1.75M	$ 1.61M	$ 1.69M
Total Liabilities	$ 13.67M	$ 12.74M	$ 10.34M	$ 8.97M	$ 7.78M
Stockholders' Equity	$ -11.22M	$ -12.12M	$ -9.82M	$ -8.08M	$ -6.84M
Cash Flow
Free Cash Flow	$ -2.30M	$ -1.10M	$ -1.85M	$ -2.04M	$ -3.59M
Operating Cash Flow	$ -2.30M	$ -1.10M	$ -1.85M	$ -2.04M	$ -3.54M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -50.00K
Financing Cash Flow	$ 2.35M	$ 1.12M	$ 1.85M	$ 2.02M	$ 3.08M

Currency in USD

BioCorRx Earnings and Revenue History

Income Statement >

BioCorRx Debt to Assets

Balance Sheet >

BioCorRx Cash Flow

Cash Flow >

BioCorRx Forecast EPS vs Actual EPS

Earnings >